Our top pick for
Building a portfolio
Inovalon Holdings, Inc is a health information services business based in the US. Inovalon shares (INOV) are listed on the NASDAQ and all prices are listed in US Dollars. Inovalon employs 2,371 staff and has a trailing 12-month revenue of around USD$651.3 million.
|Latest market close||USD$22.44|
|52-week range||USD$13.39 - USD$27.9|
|50-day moving average||USD$18.8975|
|200-day moving average||USD$22.1249|
|Wall St. target price||USD$24.81|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$0.038|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-01-15)||-14.94%|
|1 month (2020-12-22)||21.10%|
|3 months (2020-10-22)||-15.99%|
|6 months (2020-07-22)||12.37%|
|1 year (2020-01-22)||9.14%|
|2 years (2019-01-22)||55.94%|
|3 years (2018-01-22)||63.80%|
|5 years (2016-01-22)||31.30%|
Valuing Inovalon stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Inovalon's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Inovalon's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 487x. In other words, Inovalon shares trade at around 487x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Inovalon's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 5.24. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Inovalon's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Inovalon's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$178.5 million.
The EBITDA is a measure of a Inovalon's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$651.3 million|
|Operating margin TTM||9.97%|
|Gross profit TTM||USD$474.6 million|
|Return on assets TTM||2.1%|
|Return on equity TTM||0.87%|
|Market capitalisation||USD$2.9 billion|
TTM: trailing 12 months
There are currently 3.7 million Inovalon shares held short by investors – that's known as Inovalon's "short interest". This figure is 14% up from 3.3 million last month.
There are a few different ways that this level of interest in shorting Inovalon shares can be evaluated.
Inovalon's "short interest ratio" (SIR) is the quantity of Inovalon shares currently shorted divided by the average quantity of Inovalon shares traded daily (recently around 574448.21705426). Inovalon's SIR currently stands at 6.45. In other words for every 100,000 Inovalon shares traded daily on the market, roughly 6450 shares are currently held short.
However Inovalon's short interest can also be evaluated against the total number of Inovalon shares, or, against the total number of tradable Inovalon shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Inovalon's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Inovalon shares in existence, roughly 20 shares are currently held short) or 0.0501% of the tradable shares (for every 100,000 tradable Inovalon shares, roughly 50 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Inovalon.
Find out more about how you can short Inovalon stock.
We're not expecting Inovalon to pay a dividend over the next 12 months.
Over the last 12 months, Inovalon's shares have ranged in value from as little as $13.39 up to $27.9. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Inovalon's is 0.6609. This would suggest that Inovalon's shares are less volatile than average (for this exchange).
Inovalon Holdings, Inc. provides cloud-based platforms for data-driven healthcare. It operates Inovalon ONE Platform, a cloud-based platform that interconnect with the healthcare ecosystem to aggregate and analyze data in real-time, as well as empowers the application in resulting insights. The company also operates myABILITY software platform, an integrated set of cloud-based applications for providers that offers connectivity, administrative, clinical and quality analysis, management, and performance improvement capabilities to acute, post-acute, and ambulatory point-of-care provider facilities. In addition, it offers advisory, implementation, and support services. The company serves health plans and provider organizations, as well as pharmaceutical, medical device, and diagnostics companies. Its platforms include information of data pertaining to approximately 988,000 physicians; 522,000 clinical facilities; and approximately 314 million individuals and 53 billion medical events. Inovalon Holdings, Inc. was founded in 1998 and is headquartered in Bowie, Maryland.
Steps to owning and managing SSNC, with 24-hour and historical pricing before you buy.
Steps to owning and managing SMBC, with 24-hour and historical pricing before you buy.
Steps to owning and managing SMED, with 24-hour and historical pricing before you buy.
Steps to owning and managing SJW, with 24-hour and historical pricing before you buy.
Steps to owning and managing SFBS, with 24-hour and historical pricing before you buy.
Steps to owning and managing LEDS, with 24-hour and historical pricing before you buy.
Steps to owning and managing SC, with 24-hour and historical pricing before you buy.
Steps to owning and managing RTW, with 24-hour and historical pricing before you buy.
Steps to owning and managing RIVE, with 24-hour and historical pricing before you buy.
Steps to owning and managing RVSB, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.